Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 1.00 |
| ▸ | TAOK3 | Q9H2K8 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.66 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
| ▸ | RECQL | P46063 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5655807 | 1.00 | TAOK1 (1.00) | TAOK1TAOK3MAPTSMN1; SMN2RXFP1 | |
| SCHEMBL13091133 | 0.80 | TAOK1 (0.67) | TAOK1TAOK3MAPTSMN1; SMN2RXFP1 | |
| SCHEMBL5652363 | 0.76 | SMN1; SMN2 (0.76) | TAOK1TAOK3MAPTSMN1; SMN2RXFP1 | |
| SCHEMBL5652987 | 0.72 | TAOK1 (0.56) | TAOK1TAOK3MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL13091006 | 0.68 | SMN1; SMN2 (0.78) | MAPTSMN1; SMN2RXFP1ALDH1A1RECQL | |
| SCHEMBL16872917 | 0.66 | SMN1; SMN2 (0.73) | MAPTSMN1; SMN2RXFP1ALDH1A1RECQL | |
| SCHEMBL15613301 | 0.66 | SMN1; SMN2 (0.73) | MAPTSMN1; SMN2RXFP1ALDH1A1RECQL | |
| SCHEMBL16872898 | 0.65 | ALDH1A1 (0.80) | MAPTSMN1; SMN2RXFP1ALDH1A1RECQL | |
| SCHEMBL19665251 | 0.65 | MPO (0.67) | MAPTSMN1; SMN2RXFP1ALDH1A1RECQL | |
| SCHEMBL5650906 | 0.65 | RAB9A (0.61) | TAOK1MAPTSMN1; SMN2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354151-A1 | INHIBITORY AGENT FOR MYOCARDIAL CELL DEATH, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR MYOCARDIAL DISORDERS OR HEART FAILURE | KYOTO PREFECTURAL PUBLIC UNIV CORP (JP) | 2025-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250354151-A1 | INHIBITORY AGENT FOR MYOCARDIAL CELL DEATH, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR MYOCARDIAL DISORDERS OR HEART FAILURE | TNNI3, TNNC1, TNNT2 | TAOK1 7/4885TAOK3 16/4885MAPT 4762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.